Cresset Biomolecular Discovery

From Wikipedia, the free encyclopedia
Cresset
Industry Drug Discovery, Chemistry Software
Founded 2002
Founder(s) Dr. Andy Vinter
Headquarters Cambridgeshire, United Kingdom
Key people Rob Scoffin, CEO,
Website www.cresset-group.com

Cresset is a chemistry software company formed in 2002, specializing in virtual screening technology used in computational chemistry and medicinal chemistry. The company is based in the UK and sells mainly to pharmaceutical, biotechnology and academic research groups. Cresset software is based upon field point technology,[1] which uses molecular field extrema as a means of finding biologically relevant regions of molecules.

Cresset's products have traditionally solveed key problems faced by computational chemists, such as ligand based virtual screening (Blaze), bioisostere identification (Spark), bioactive conformation determination (Forge) and ligand alignment (Torch). However, our field technology has been adopted in a wide range of markets involved in all aspects of molecule discovery and design.

Cresset has partnerships with pharmaceutical, contract research, software, and information organisations including Syrris, PerkinElmer Informatics, Peakdale Molecular and Optibrium.

Products

References

External links

Other institutions developing software for computational chemistry

This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.